Unknown

Dataset Information

Short, frequent, 5-days-per-week, in-center hemodialysis versus 3-days-per week treatment: a randomized crossover pilot trial through the Midwest Pediatric Nephrology Consortium.


ABSTRACT:

Background

No controlled trials in children with end-stage kidney disease have assessed the benefits of more frequently administered hemodialysis (HD).

Methods

We conducted a multicenter, crossover pilot trial to determine if short, more frequent (5 days per week) in-center HD was feasible and associated with improvements in blood pressure compared with three conventional HD treatments per week. Because adult studies have not controlled for the weekly duration of dialysis, we fixed the total treatment time at 12 h a week of dialysis during two 3-month study periods; only frequency varied from 5 to 3 days per week between study periods.

Results

Eight children (median age 16.7 years) consented at three children's hospitals. The prespecified primary composite outcome was

SUBMITTER: Laskin BL 

PROVIDER: S-EPMC5485844 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature